In Psoriatic Arthritis, Doubling Down on IL-17 Bimekizumab targets both IL-17A and F; "astonishing" results in psoriatic arthritis Oct 25, 2018
RA Guideline Adherence Spotty, Study Finds Treat-to-target recommendation not followed for half of patients Oct 23, 2018
New JAK1 Agent Beats Humira in Rheumatoid Arthritis Thrombotic events balanced between upadacitinib, adalimumab, and placebo Oct 22, 2018
Understanding Neuropathic-Like Knee Pain Central risk factors may contribute to the condition, study shows Oct 13, 2018
Repeat CRP Tests If Spine Disease Uncertain Post-hoc analysis of patients with axial spondyloarthritis Sep 17, 2018
Nurses Can Lead the Way in Research ACR and EULAR studies demonstrated that research "is an important part of what we do" Aug 11, 2018
Minimal Disease Activity: The Goal in PsA Validity confirmed in large population of patients Jul 19, 2018
Enthesitis in PsA: A New Focus of Treatment? Targeting IL-23 with ustekinumab cleared enthesitis in three-quarters of patients Jun 22, 2018
Cardiovascular Risk in RA: Beyond Inflammation? With adverse lifestyle plus bad genes plus inflammation, 'you unleash hell' Jun 16, 2018
Weight, Smoking Inhibit RA Remission Factors differ for women and men, but both relate to lifestyle Jun 15, 2018
Meds Improve Cardiovascular Risk in RA Benefits seen for hydroxychloroquine, methotrexate, and tocilizumab Jun 15, 2018
Inflammatory Eye Disease: Complex, Scary Often related to autoimmune, inflammatory diseases May 10, 2018
RA Therapy: After Methotrexate, Then What? Strong preference for anti-TNF therapy despite emerging data May 09, 2018
Tocilizumab Beats Anti-TNFs for Treatment Retention Longer time on treatment, regardless of additional DMARDs May 08, 2018
RA Patients Pose Perioperative Challenges Expert discusses risk evaluation, stopping antirheumatic drugs May 07, 2018
Biosimilar Switch Succeeds in Single Center Disease activity scores improved significantly after the change in rheumatoid arthritis patients May 04, 2018
Shocker! Is Vioxx Coming Back... as an Orphan Drug? Milton Packer wonders whether its return represents innovation or opportunism May 02, 2018
Troponin Predicts Mortality in Inflammatory Arthritis High levels associated with all-cause and cardiovascular death May 01, 2018
FDA Panel Gives Celecoxib Positive CV Safety Grade Votes 15-5 that it is non-inferior to naproxen, ibuprofen Apr 25, 2018
Respect the Needle in OA Patients may be experiencing placebo effect, but it's still an effect, rheumatologist says Apr 19, 2018
Young Arthritis Patients Fare Worse on MTX High disease activity also linked with drug failure Mar 23, 2018
Novel Tx Eases Osteoarthritic Knee Pain Geniculate artery embolization promising for knee pain, stiffness Mar 18, 2018
Death Strikes Young in RA Most common causes were circulatory, respiratory, and malignancy Mar 07, 2018
One Gout Medication Comes Out on Top for CV Risk Allopurinol the loser in retrospective comparison of two drugs Feb 26, 2018
Cancer Risk Stable in Kids on Anti-TNFs But background risks higher than in the general population Feb 20, 2018
Selective IL-23 Inhibitor Shines in Mid-Stage PsA Trial Risankizumab broadly effective against joint and skin symptoms Nov 09, 2017
PsA Structural Damage Inhibited with Secukinumab Loading dose appears to improve outcomes, researchers say Nov 09, 2017
ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologics Selections from late-breaker poster presentations at rheumatology meeting Nov 08, 2017
Biologics During Pregnancy Don't Raise Infection Risk for Infants Gestational timing of exposure to biologic not an issue Nov 07, 2017
Lipid Changes with Sirukumab Called 'Anti-Atherogenic' Looking for silver-lining in cloudy trial data Nov 06, 2017
Bruton's Tyrosine Kinase Marches on as Rheumatology Target Industry remains interested despite lackluster phase II results with Celgene drug Nov 06, 2017
Injecting Arthritic Knees Carries Sepsis Risk Study identified four risk factors for sepsis after injections for knee pain. Nov 06, 2017
In RA Patients, 2-Week Methotrexate Holiday Boosts Flu Vax Efficacy Pragmatic trial shows 15%-20% bump in antibody titers Nov 05, 2017
ACR 2017: Biosimilar Debate, Inflammation in OA, and More Special lecture will look back at TNF as rheumatology drug target Nov 03, 2017
Helping Kids with Chronic Diseases Move to Adult Care Program at Wisconsin hospital develops self-management skills Aug 13, 2017
Tofacitinib Shows MRI Benefits in AS Improvements seen on MRI for both sacroiliac joints and spine Jun 16, 2017
